Literature DB >> 21777926

Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs.

Caroline M Meers1, Shana Wauters, Eric Verbeken, Hans Scheers, Bart Vanaudenaerde, Geert M Verleden, Dirk Van Raemdonck.   

Abstract

BACKGROUND: Donor lungs are susceptible to aspiration in the period before and after brain death. We hypothesized that preemptive anti-inflammatory treatment may result in better graft performance as evaluated during ex vivo lung perfusion (EVLP).
METHODS: Pigs (27.4 ± 8.3kg) were divided into four groups (n = 6). Group [S] was treated with steroids (methylprednisolone 10 mg/kg), group [M] with macrolides (clarithromycin 250 mg), and group [P] with placebo (saline). In all groups, treatment was given i.v. 25, 18, and 1 h before instillation of 4 mL/kg gastric juice (GJ). Group [C] without GJ instillation served as a control group. Two hours after the onset of acute lung injury, lungs were flushed, explanted, and stored cold for 75 min. Graft performance was then assessed during EVLP for 2 h. Aerodynamic and hemodynamic parameters and oxygenation capacity (∆PO(2)) were recorded every 30 min (T30-T120). BAL samples were collected and analyzed for total and differential cells, IL-6, IL-1β, 8- isoprostane, and CRP levels. Wet-to-dry weight ratio [W/D] was measured and tissue samples were collected for histology.
RESULTS: ΔPO(2) in [S] was comparable to [C] and was higher versus [M] (P < 0.05) and [P] (P < 0.01). No differences were observed in pulmonary vascular resistance, lung compliance, and mean airway pressure. No additional edema was noticed after 2 h of EVLP. Cellular and biomolecular changes in BAL fluid and histologic alterations were comparable among the three study groups.
CONCLUSION: Preemptive treatment of donors with steroids but not macrolides improves gas exchange in a porcine lung injury model independently from its anti-inflammatory activity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777926     DOI: 10.1016/j.jss.2011.05.062

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

Review 1.  Machine perfusion of thoracic organs.

Authors:  Dirk Van Raemdonck; Filip Rega; Steffen Rex; Arne Neyrinck
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Primary graft dysfunction: pathophysiology to guide new preventive therapies.

Authors:  Ciara M Shaver; Lorraine B Ware
Journal:  Expert Rev Respir Med       Date:  2017-01-20       Impact factor: 3.772

Review 3.  Ex Vivo Lung Perfusion: Current Achievements and Future Directions.

Authors:  Nikhil K Prasad; Chetan Pasrija; Tara Talaie; Alexander S Krupnick; Yunge Zhao; Christine L Lau
Journal:  Transplantation       Date:  2021-05-01       Impact factor: 4.939

4.  Multiparametric MRI for organ quality assessment in a porcine Ex-Vivo lung perfusion system.

Authors:  Julius Renne; Marcel Gutberlet; Andreas Voskrebenzev; Agilo Kern; Till Kaireit; Jan Hinrichs; Patrick Zardo; Gregor Warnecke; Marcus Krüger; Peter Braubach; Danny Jonigk; Axel Haverich; Frank Wacker; Jens Vogel-Claussen; Norman Zinne
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

Review 5.  Primary graft dysfunction after heart transplantation: a thorn amongst the roses.

Authors:  Sanjeet Singh Avtaar Singh; Jonathan R Dalzell; Colin Berry; Nawwar Al-Attar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.